154 related articles for article (PubMed ID: 12196040)
1. Monoclonal antibody therapy of haematological malignancies.
Dearden C
BioDrugs; 2002; 16(4):283-301. PubMed ID: 12196040
[TBL] [Abstract][Full Text] [Related]
2. Role of antibody therapy in lymphoid malignancies.
Dearden CE
Br Med Bull; 2007; 83():275-90. PubMed ID: 17942451
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
Rao AV; Schmader K
Am J Geriatr Pharmacother; 2007 Sep; 5(3):247-62. PubMed ID: 17996665
[TBL] [Abstract][Full Text] [Related]
4. Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies.
Tsirigotis P; Savani BN; Nagler A
Ann Med; 2016 Sep; 48(6):428-439. PubMed ID: 27224873
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody therapy in haematological malignancies.
Chamuleau ME; van de Loosdrecht AA; Huijgens PC
Curr Clin Pharmacol; 2010 Aug; 5(3):148-59. PubMed ID: 20406175
[TBL] [Abstract][Full Text] [Related]
6. Biological Therapy of Hematologic Malignancies: Toward a Chemotherapy- free Era.
Klener P; Etrych T; Klener P
Curr Med Chem; 2019; 26(6):1002-1018. PubMed ID: 28990505
[TBL] [Abstract][Full Text] [Related]
7. Future of monoclonal antibodies in the treatment of hematologic malignancies.
Reff ME; Hariharan K; Braslawsky G
Cancer Control; 2002; 9(2):152-66. PubMed ID: 11965235
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies in the treatment of hematopoietic malignancies.
Houghton A; Scheinberg D
Semin Hematol; 1988 Jul; 25(3 Suppl 3):23-9. PubMed ID: 3051406
[TBL] [Abstract][Full Text] [Related]
9. New antibody approaches to lymphoma therapy.
Suresh T; Lee LX; Joshi J; Barta SK
J Hematol Oncol; 2014 Sep; 7():58. PubMed ID: 25355407
[TBL] [Abstract][Full Text] [Related]
10. New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies.
Robak T; Robak E
BioDrugs; 2011 Feb; 25(1):13-25. PubMed ID: 21090841
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method.
Khademi F; Mostafaie A; Parvaneh S; Gholami Rad F; Mohammadi P; Bahrami G
Int Immunopharmacol; 2017 Feb; 43():23-32. PubMed ID: 27939822
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic monoclonal antibodies for hematological diseases].
Harada T; Abe M
Nihon Rinsho; 2014 Jun; 72(6):1143-8. PubMed ID: 25016818
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy for hematologic malignancies.
Kuriakose P
Cancer Control; 2005 Apr; 12(2):82-90. PubMed ID: 15855891
[TBL] [Abstract][Full Text] [Related]
14. Prospects for monoclonal antibody therapy of leukemia and lymphoma.
Badger CC; Bernstein ID
Cancer; 1986 Jul; 58(2 Suppl):584-9. PubMed ID: 3521840
[TBL] [Abstract][Full Text] [Related]
15. Newer monoclonal antibodies for hematological malignancies.
Castillo J; Winer E; Quesenberry P
Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
[TBL] [Abstract][Full Text] [Related]
16. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
[TBL] [Abstract][Full Text] [Related]
17. Antibodies in oncology.
Pillay V; Gan HK; Scott AM
N Biotechnol; 2011 Sep; 28(5):518-29. PubMed ID: 21473941
[TBL] [Abstract][Full Text] [Related]
18. New monoclonal antibodies in renal transplantation.
Vincenti F
Minerva Urol Nefrol; 2003 Mar; 55(1):57-66. PubMed ID: 12773967
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal Antibodies.
Geskin LJ
Dermatol Clin; 2015 Oct; 33(4):777-86. PubMed ID: 26433849
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies in the treatment of hematologic malignancies: radiation dosimetry aspects.
Stabin MG; Brill AB
Curr Pharm Biotechnol; 2001 Dec; 2(4):351-6. PubMed ID: 11762416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
